Mineralys Therapeutics (MLYS) EPS (Weighted Average and Diluted) (2022 - 2026)
Quarterly results put EPS (Weighted Average and Diluted) at -$0.47 for Q1 2026, up 40.51% from a year ago — trailing twelve months through Mar 2026 was -$2.0 (up 46.38% YoY), and the annual figure for FY2025 was -$2.29, up 37.43%.
Mineralys Therapeutics has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at -$0.47 for Q1 2026.
- EPS (Weighted Average and Diluted) reached -$0.47 in Q1 2026 per MLYS's latest filing, down from -$0.35 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.31 in Q2 2023 and bottomed at -$1.75 in Q4 2022.
- Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.7 (2024), compared with a mean of -$0.84.
- The largest annual shift saw EPS (Weighted Average and Diluted) surged 75.4% in 2023 before it plummeted 167.74% in 2024.
- Over 5 years, EPS (Weighted Average and Diluted) stood at -$1.75 in 2022, then surged by 64.0% to -$0.63 in 2023, then plummeted by 55.56% to -$0.98 in 2024, then surged by 64.29% to -$0.35 in 2025, then tumbled by 34.29% to -$0.47 in 2026.
- Business Quant data shows EPS (Weighted Average and Diluted) for MLYS at -$0.47 in Q1 2026, -$0.35 in Q4 2025, and -$0.52 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.02 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.75 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.51 |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -0.98 |
| Sep 30, 2024 | -1.13 |
| Jun 30, 2024 | -0.83 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.63 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.31 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -1.75 |
| Sep 30, 2022 | -1.29 |
| Jun 30, 2022 | -1.26 |
| Mar 31, 2022 | -1.48 |